US Patent Issued to Humabs BioMed on May 20 for "Antibodies that neutralize hepatitis B virus and uses thereof" (Swiss Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,946, issued on May 20, was assigned to Humabs BioMed SA (Bellinzona, Switzerland).

"Antibodies that neutralize hepatitis B virus and uses thereof" was invented by Davide Corti (Bellinzona, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies, and antigen binding fragments thereof, that can bind to the antigenic loop region of hepatitis B surface antigen (HBsAg) and can neutralize infection of both hepatitis B virus (HBV) and hepatitis delta virus (HDV). The present disclosure also relates to epitopes to which the antibodies and antigen binding fragments bind, as well as to fusion proteins that compr...